nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—SLC15A2—Trandolapril—coronary artery disease	0.105	0.148	CbGbCtD
Valganciclovir—SLC15A2—Perindopril—coronary artery disease	0.0958	0.135	CbGbCtD
Valganciclovir—SLC15A1—Trandolapril—coronary artery disease	0.0902	0.127	CbGbCtD
Valganciclovir—SLC15A1—Perindopril—coronary artery disease	0.0825	0.116	CbGbCtD
Valganciclovir—SLC15A2—Ramipril—coronary artery disease	0.0793	0.112	CbGbCtD
Valganciclovir—SLC15A1—Lisinopril—coronary artery disease	0.0683	0.0964	CbGbCtD
Valganciclovir—SLC15A1—Ramipril—coronary artery disease	0.0683	0.0964	CbGbCtD
Valganciclovir—SLC15A1—Enalapril—coronary artery disease	0.0683	0.0964	CbGbCtD
Valganciclovir—SLC15A1—Captopril—coronary artery disease	0.0512	0.0722	CbGbCtD
Valganciclovir—SLC6A14—Na+/Cl- dependent neurotransmitter transporters—SLC6A6—coronary artery disease	0.00484	0.0956	CbGpPWpGaD
Valganciclovir—SLC6A14—Amine compound SLC transporters—SLC6A6—coronary artery disease	0.00336	0.0663	CbGpPWpGaD
Valganciclovir—SLC6A14—Amino acid transport across the plasma membrane—SLC6A6—coronary artery disease	0.00327	0.0646	CbGpPWpGaD
Valganciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC6A6—coronary artery disease	0.00227	0.0448	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—PRDX6—coronary artery disease	0.00147	0.029	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—CES3—coronary artery disease	0.00147	0.029	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC6A6—coronary artery disease	0.00134	0.0264	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A6—coronary artery disease	0.00131	0.0259	CbGpPWpGaD
Valganciclovir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC6A6—coronary artery disease	0.00107	0.0212	CbGpPWpGaD
Valganciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC6A6—coronary artery disease	0.000996	0.0197	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC6A6—coronary artery disease	0.000947	0.0187	CbGpPWpGaD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—coronary artery disease	0.000912	0.018	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—coronary artery disease	0.000847	0.0167	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—coronary artery disease	0.000795	0.0157	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GSTM2—coronary artery disease	0.000794	0.0157	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SOD3—coronary artery disease	0.00064	0.0126	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GCLM—coronary artery disease	0.00064	0.0126	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC6A6—coronary artery disease	0.000632	0.0125	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—TXNRD1—coronary artery disease	0.00062	0.0122	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC6A6—coronary artery disease	0.000597	0.0118	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—coronary artery disease	0.000595	0.0117	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC6A6—coronary artery disease	0.000587	0.0116	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GPX2—coronary artery disease	0.00057	0.0113	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GSTA1—coronary artery disease	0.00055	0.0109	CbGpPWpGaD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—coronary artery disease	0.000478	0.00943	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GPX3—coronary artery disease	0.000463	0.00913	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—HK2—coronary artery disease	0.000453	0.00893	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC27A1—coronary artery disease	0.000434	0.00856	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GCLC—coronary artery disease	0.000417	0.00823	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—TGFB2—coronary artery disease	0.000395	0.0078	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC22A3—coronary artery disease	0.000385	0.0076	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—coronary artery disease	0.000376	0.00742	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000357	0.00704	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—HK1—coronary artery disease	0.000355	0.00701	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	0.000355	0.00701	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—coronary artery disease	0.000349	0.00688	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—HSPA1A—coronary artery disease	0.000348	0.00687	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GGT1—coronary artery disease	0.000326	0.00643	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000318	0.00628	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000318	0.00628	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000303	0.00599	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GSTP1—coronary artery disease	0.000292	0.00577	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—TGFBR2—coronary artery disease	0.000292	0.00577	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—HMOX1—coronary artery disease	0.000288	0.00569	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC6A6—coronary artery disease	0.000282	0.00557	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—coronary artery disease	0.000281	0.00556	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GSTM1—coronary artery disease	0.000269	0.0053	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—HGF—coronary artery disease	0.000269	0.0053	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	0.000266	0.00525	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC6A6—coronary artery disease	0.000262	0.00517	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—coronary artery disease	0.000261	0.00516	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—AGER—coronary artery disease	0.000259	0.00512	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000254	0.00502	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000254	0.00502	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000247	0.00488	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—HK2—coronary artery disease	0.00023	0.00454	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.00022	0.00435	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.00022	0.00435	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—HK2—coronary artery disease	0.000214	0.00422	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC27A1—coronary artery disease	0.000205	0.00405	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—HK2—coronary artery disease	0.000199	0.00392	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.000196	0.00386	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.000196	0.00386	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC27A1—coronary artery disease	0.00019	0.00376	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC22A3—coronary artery disease	0.000182	0.00359	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ABCG5—coronary artery disease	0.00018	0.00356	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—HK1—coronary artery disease	0.00018	0.00356	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	0.00018	0.00356	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC22A3—coronary artery disease	0.000169	0.00333	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000169	0.00333	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	0.000168	0.00332	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—HK1—coronary artery disease	0.000168	0.00332	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000157	0.00309	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—HK1—coronary artery disease	0.000156	0.00308	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	0.000156	0.00308	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.00015	0.00297	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.00015	0.00297	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000144	0.00283	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.00014	0.00276	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.00014	0.00276	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	0.000138	0.00273	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	0.000135	0.00267	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—CETP—coronary artery disease	0.000134	0.00264	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000133	0.00263	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—TFRC—coronary artery disease	0.000127	0.0025	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	0.000126	0.00248	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.00012	0.00237	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.00012	0.00237	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—PLAT—coronary artery disease	0.000118	0.00232	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000117	0.00231	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	0.000117	0.0023	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000112	0.0022	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000112	0.0022	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—TGFB1—coronary artery disease	0.00011	0.00216	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—coronary artery disease	0.000109	0.00215	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000109	0.00215	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000109	0.00214	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000104	0.00206	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000104	0.00206	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000101	0.00199	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—PLG—coronary artery disease	0.0001	0.00198	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	9.68e-05	0.00191	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ATP4A—coronary artery disease	9.68e-05	0.00191	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	9.25e-05	0.00183	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	9.25e-05	0.00183	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—HMOX1—coronary artery disease	9.24e-05	0.00182	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—APOB—coronary artery disease	8.85e-05	0.00175	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	8.58e-05	0.00169	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	8.58e-05	0.00169	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	8.54e-05	0.00168	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—HK1—coronary artery disease	8.54e-05	0.00168	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	8.54e-05	0.00168	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ABCG5—coronary artery disease	7.92e-05	0.00156	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—HK1—coronary artery disease	7.92e-05	0.00156	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	7.92e-05	0.00156	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—APOA1—coronary artery disease	7e-05	0.00138	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	6.55e-05	0.00129	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	6.39e-05	0.00126	CbGpPWpGaD
Valganciclovir—Dermatitis—Lovastatin—coronary artery disease	6.32e-05	0.000263	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—CETP—coronary artery disease	6.32e-05	0.00125	CbGpPWpGaD
Valganciclovir—Anaemia—Lisinopril—coronary artery disease	6.31e-05	0.000262	CcSEcCtD
Valganciclovir—Dyspepsia—Losartan—coronary artery disease	6.31e-05	0.000262	CcSEcCtD
Valganciclovir—Feeling abnormal—Perindopril—coronary artery disease	6.3e-05	0.000262	CcSEcCtD
Valganciclovir—Headache—Lovastatin—coronary artery disease	6.29e-05	0.000261	CcSEcCtD
Valganciclovir—Pruritus—Valsartan—coronary artery disease	6.27e-05	0.000261	CcSEcCtD
Valganciclovir—Dry mouth—Ramipril—coronary artery disease	6.27e-05	0.000261	CcSEcCtD
Valganciclovir—Arthralgia—Timolol—coronary artery disease	6.27e-05	0.00026	CcSEcCtD
Valganciclovir—Vomiting—Ezetimibe—coronary artery disease	6.26e-05	0.00026	CcSEcCtD
Valganciclovir—Hypersensitivity—Pravastatin—coronary artery disease	6.25e-05	0.00026	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Perindopril—coronary artery disease	6.25e-05	0.00026	CcSEcCtD
Valganciclovir—Anxiety—Timolol—coronary artery disease	6.25e-05	0.00026	CcSEcCtD
Valganciclovir—Pruritus—Olmesartan—coronary artery disease	6.24e-05	0.000259	CcSEcCtD
Valganciclovir—Decreased appetite—Losartan—coronary artery disease	6.23e-05	0.000259	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	6.23e-05	0.000259	CcSEcCtD
Valganciclovir—Body temperature increased—Captopril—coronary artery disease	6.22e-05	0.000259	CcSEcCtD
Valganciclovir—Abdominal pain—Captopril—coronary artery disease	6.22e-05	0.000259	CcSEcCtD
Valganciclovir—Dizziness—Simvastatin—coronary artery disease	6.21e-05	0.000258	CcSEcCtD
Valganciclovir—Dermatitis—Ezetimibe—coronary artery disease	6.2e-05	0.000258	CcSEcCtD
Valganciclovir—Confusional state—Ramipril—coronary artery disease	6.2e-05	0.000257	CcSEcCtD
Valganciclovir—Discomfort—Timolol—coronary artery disease	6.19e-05	0.000257	CcSEcCtD
Valganciclovir—Asthenia—Niacin—coronary artery disease	6.18e-05	0.000257	CcSEcCtD
Valganciclovir—Fatigue—Losartan—coronary artery disease	6.18e-05	0.000257	CcSEcCtD
Valganciclovir—Headache—Ezetimibe—coronary artery disease	6.17e-05	0.000256	CcSEcCtD
Valganciclovir—Malaise—Lisinopril—coronary artery disease	6.16e-05	0.000256	CcSEcCtD
Valganciclovir—Oedema—Ramipril—coronary artery disease	6.15e-05	0.000255	CcSEcCtD
Valganciclovir—Anaphylactic shock—Ramipril—coronary artery disease	6.15e-05	0.000255	CcSEcCtD
Valganciclovir—Vertigo—Lisinopril—coronary artery disease	6.14e-05	0.000255	CcSEcCtD
Valganciclovir—Dry mouth—Timolol—coronary artery disease	6.13e-05	0.000255	CcSEcCtD
Valganciclovir—Constipation—Losartan—coronary artery disease	6.13e-05	0.000255	CcSEcCtD
Valganciclovir—Pain—Losartan—coronary artery disease	6.13e-05	0.000255	CcSEcCtD
Valganciclovir—Vomiting—Eplerenone—coronary artery disease	6.13e-05	0.000254	CcSEcCtD
Valganciclovir—Feeling abnormal—Furosemide—coronary artery disease	6.12e-05	0.000254	CcSEcCtD
Valganciclovir—Leukopenia—Lisinopril—coronary artery disease	6.11e-05	0.000254	CcSEcCtD
Valganciclovir—Nausea—Fenofibrate—coronary artery disease	6.1e-05	0.000254	CcSEcCtD
Valganciclovir—Pruritus—Niacin—coronary artery disease	6.1e-05	0.000253	CcSEcCtD
Valganciclovir—Asthenia—Pravastatin—coronary artery disease	6.09e-05	0.000253	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	6.08e-05	0.0012	CbGpPWpGaD
Valganciclovir—Gastrointestinal pain—Furosemide—coronary artery disease	6.08e-05	0.000252	CcSEcCtD
Valganciclovir—Urticaria—Perindopril—coronary artery disease	6.07e-05	0.000252	CcSEcCtD
Valganciclovir—Hypersensitivity—Trandolapril—coronary artery disease	6.07e-05	0.000252	CcSEcCtD
Valganciclovir—Dermatitis—Eplerenone—coronary artery disease	6.07e-05	0.000252	CcSEcCtD
Valganciclovir—Diarrhoea—Valsartan—coronary artery disease	6.06e-05	0.000252	CcSEcCtD
Valganciclovir—Confusional state—Timolol—coronary artery disease	6.06e-05	0.000252	CcSEcCtD
Valganciclovir—Hypersensitivity—Enalapril—coronary artery disease	6.05e-05	0.000251	CcSEcCtD
Valganciclovir—Body temperature increased—Perindopril—coronary artery disease	6.04e-05	0.000251	CcSEcCtD
Valganciclovir—Abdominal pain—Perindopril—coronary artery disease	6.04e-05	0.000251	CcSEcCtD
Valganciclovir—Diarrhoea—Olmesartan—coronary artery disease	6.04e-05	0.000251	CcSEcCtD
Valganciclovir—Headache—Eplerenone—coronary artery disease	6.04e-05	0.000251	CcSEcCtD
Valganciclovir—Nervous system disorder—Ramipril—coronary artery disease	6.03e-05	0.00025	CcSEcCtD
Valganciclovir—Thrombocytopenia—Ramipril—coronary artery disease	6.02e-05	0.00025	CcSEcCtD
Valganciclovir—Anaphylactic shock—Timolol—coronary artery disease	6.01e-05	0.00025	CcSEcCtD
Valganciclovir—Oedema—Timolol—coronary artery disease	6.01e-05	0.00025	CcSEcCtD
Valganciclovir—Pruritus—Pravastatin—coronary artery disease	6e-05	0.000249	CcSEcCtD
Valganciclovir—Nausea—Clopidogrel—coronary artery disease	6e-05	0.000249	CcSEcCtD
Valganciclovir—Tachycardia—Ramipril—coronary artery disease	6e-05	0.000249	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—TFRC—coronary artery disease	5.99e-05	0.00118	CbGpPWpGaD
Valganciclovir—Skin disorder—Ramipril—coronary artery disease	5.97e-05	0.000248	CcSEcCtD
Valganciclovir—Infection—Timolol—coronary artery disease	5.97e-05	0.000248	CcSEcCtD
Valganciclovir—Vomiting—Simvastatin—coronary artery disease	5.97e-05	0.000248	CcSEcCtD
Valganciclovir—Hypersensitivity—Telmisartan—coronary artery disease	5.96e-05	0.000248	CcSEcCtD
Valganciclovir—Cough—Lisinopril—coronary artery disease	5.96e-05	0.000248	CcSEcCtD
Valganciclovir—Nausea—Lovastatin—coronary artery disease	5.96e-05	0.000248	CcSEcCtD
Valganciclovir—Hyperhidrosis—Ramipril—coronary artery disease	5.94e-05	0.000247	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	5.93e-05	0.00117	CbGpPWpGaD
Valganciclovir—Dermatitis—Simvastatin—coronary artery disease	5.91e-05	0.000246	CcSEcCtD
Valganciclovir—Asthenia—Trandolapril—coronary artery disease	5.91e-05	0.000246	CcSEcCtD
Valganciclovir—Feeling abnormal—Losartan—coronary artery disease	5.91e-05	0.000245	CcSEcCtD
Valganciclovir—Urticaria—Furosemide—coronary artery disease	5.9e-05	0.000245	CcSEcCtD
Valganciclovir—Diarrhoea—Niacin—coronary artery disease	5.9e-05	0.000245	CcSEcCtD
Valganciclovir—Nervous system disorder—Timolol—coronary artery disease	5.89e-05	0.000245	CcSEcCtD
Valganciclovir—Asthenia—Enalapril—coronary artery disease	5.89e-05	0.000245	CcSEcCtD
Valganciclovir—Headache—Simvastatin—coronary artery disease	5.88e-05	0.000244	CcSEcCtD
Valganciclovir—Abdominal pain—Furosemide—coronary artery disease	5.87e-05	0.000244	CcSEcCtD
Valganciclovir—Body temperature increased—Furosemide—coronary artery disease	5.87e-05	0.000244	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—CETP—coronary artery disease	5.86e-05	0.00116	CbGpPWpGaD
Valganciclovir—Gastrointestinal pain—Losartan—coronary artery disease	5.86e-05	0.000244	CcSEcCtD
Valganciclovir—Dizziness—Valsartan—coronary artery disease	5.86e-05	0.000244	CcSEcCtD
Valganciclovir—Anorexia—Ramipril—coronary artery disease	5.86e-05	0.000243	CcSEcCtD
Valganciclovir—Nausea—Ezetimibe—coronary artery disease	5.85e-05	0.000243	CcSEcCtD
Valganciclovir—Skin disorder—Timolol—coronary artery disease	5.84e-05	0.000242	CcSEcCtD
Valganciclovir—Dizziness—Olmesartan—coronary artery disease	5.83e-05	0.000242	CcSEcCtD
Valganciclovir—Pruritus—Trandolapril—coronary artery disease	5.83e-05	0.000242	CcSEcCtD
Valganciclovir—Arthralgia—Lisinopril—coronary artery disease	5.82e-05	0.000242	CcSEcCtD
Valganciclovir—Hyperhidrosis—Timolol—coronary artery disease	5.81e-05	0.000241	CcSEcCtD
Valganciclovir—Asthenia—Telmisartan—coronary artery disease	5.81e-05	0.000241	CcSEcCtD
Valganciclovir—Pruritus—Enalapril—coronary artery disease	5.81e-05	0.000241	CcSEcCtD
Valganciclovir—Diarrhoea—Pravastatin—coronary artery disease	5.81e-05	0.000241	CcSEcCtD
Valganciclovir—Anxiety—Lisinopril—coronary artery disease	5.8e-05	0.000241	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	5.78e-05	0.00024	CcSEcCtD
Valganciclovir—Discomfort—Lisinopril—coronary artery disease	5.75e-05	0.000239	CcSEcCtD
Valganciclovir—Hypotension—Ramipril—coronary artery disease	5.74e-05	0.000239	CcSEcCtD
Valganciclovir—Anorexia—Timolol—coronary artery disease	5.73e-05	0.000238	CcSEcCtD
Valganciclovir—Pruritus—Telmisartan—coronary artery disease	5.73e-05	0.000238	CcSEcCtD
Valganciclovir—Nausea—Eplerenone—coronary artery disease	5.72e-05	0.000238	CcSEcCtD
Valganciclovir—Dizziness—Niacin—coronary artery disease	5.7e-05	0.000237	CcSEcCtD
Valganciclovir—Urticaria—Losartan—coronary artery disease	5.7e-05	0.000237	CcSEcCtD
Valganciclovir—Dry mouth—Lisinopril—coronary artery disease	5.69e-05	0.000236	CcSEcCtD
Valganciclovir—Body temperature increased—Losartan—coronary artery disease	5.67e-05	0.000235	CcSEcCtD
Valganciclovir—Abdominal pain—Losartan—coronary artery disease	5.67e-05	0.000235	CcSEcCtD
Valganciclovir—Asthenia—Captopril—coronary artery disease	5.65e-05	0.000235	CcSEcCtD
Valganciclovir—Diarrhoea—Trandolapril—coronary artery disease	5.64e-05	0.000234	CcSEcCtD
Valganciclovir—Vomiting—Valsartan—coronary artery disease	5.64e-05	0.000234	CcSEcCtD
Valganciclovir—Confusional state—Lisinopril—coronary artery disease	5.62e-05	0.000234	CcSEcCtD
Valganciclovir—Diarrhoea—Enalapril—coronary artery disease	5.62e-05	0.000233	CcSEcCtD
Valganciclovir—Hypotension—Timolol—coronary artery disease	5.62e-05	0.000233	CcSEcCtD
Valganciclovir—Dizziness—Pravastatin—coronary artery disease	5.61e-05	0.000233	CcSEcCtD
Valganciclovir—Vomiting—Olmesartan—coronary artery disease	5.61e-05	0.000233	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.6e-05	0.000233	CcSEcCtD
Valganciclovir—Dermatitis—Valsartan—coronary artery disease	5.58e-05	0.000232	CcSEcCtD
Valganciclovir—Nausea—Simvastatin—coronary artery disease	5.58e-05	0.000232	CcSEcCtD
Valganciclovir—Anaphylactic shock—Lisinopril—coronary artery disease	5.57e-05	0.000232	CcSEcCtD
Valganciclovir—Oedema—Lisinopril—coronary artery disease	5.57e-05	0.000232	CcSEcCtD
Valganciclovir—Pruritus—Captopril—coronary artery disease	5.57e-05	0.000231	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—PLAT—coronary artery disease	5.57e-05	0.0011	CbGpPWpGaD
Valganciclovir—Insomnia—Ramipril—coronary artery disease	5.56e-05	0.000231	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—TFRC—coronary artery disease	5.56e-05	0.0011	CbGpPWpGaD
Valganciclovir—Dermatitis—Olmesartan—coronary artery disease	5.56e-05	0.000231	CcSEcCtD
Valganciclovir—Headache—Valsartan—coronary artery disease	5.55e-05	0.000231	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—coronary artery disease	5.55e-05	0.00109	CbGpPWpGaD
Valganciclovir—Diarrhoea—Telmisartan—coronary artery disease	5.54e-05	0.00023	CcSEcCtD
Valganciclovir—Infection—Lisinopril—coronary artery disease	5.54e-05	0.00023	CcSEcCtD
Valganciclovir—Headache—Olmesartan—coronary artery disease	5.53e-05	0.00023	CcSEcCtD
Valganciclovir—Paraesthesia—Ramipril—coronary artery disease	5.52e-05	0.000229	CcSEcCtD
Valganciclovir—Asthenia—Perindopril—coronary artery disease	5.48e-05	0.000228	CcSEcCtD
Valganciclovir—Dyspnoea—Ramipril—coronary artery disease	5.48e-05	0.000228	CcSEcCtD
Valganciclovir—Vomiting—Niacin—coronary artery disease	5.48e-05	0.000228	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Timolol—coronary artery disease	5.48e-05	0.000227	CcSEcCtD
Valganciclovir—Hypersensitivity—Furosemide—coronary artery disease	5.47e-05	0.000227	CcSEcCtD
Valganciclovir—Somnolence—Ramipril—coronary artery disease	5.46e-05	0.000227	CcSEcCtD
Valganciclovir—Thrombocytopenia—Lisinopril—coronary artery disease	5.46e-05	0.000227	CcSEcCtD
Valganciclovir—Dizziness—Trandolapril—coronary artery disease	5.45e-05	0.000226	CcSEcCtD
Valganciclovir—Tachycardia—Lisinopril—coronary artery disease	5.44e-05	0.000226	CcSEcCtD
Valganciclovir—Insomnia—Timolol—coronary artery disease	5.44e-05	0.000226	CcSEcCtD
Valganciclovir—Dermatitis—Niacin—coronary artery disease	5.43e-05	0.000226	CcSEcCtD
Valganciclovir—Dizziness—Enalapril—coronary artery disease	5.43e-05	0.000225	CcSEcCtD
Valganciclovir—Skin disorder—Lisinopril—coronary artery disease	5.41e-05	0.000225	CcSEcCtD
Valganciclovir—Dyspepsia—Ramipril—coronary artery disease	5.41e-05	0.000225	CcSEcCtD
Valganciclovir—Pruritus—Perindopril—coronary artery disease	5.41e-05	0.000225	CcSEcCtD
Valganciclovir—Headache—Niacin—coronary artery disease	5.4e-05	0.000224	CcSEcCtD
Valganciclovir—Paraesthesia—Timolol—coronary artery disease	5.4e-05	0.000224	CcSEcCtD
Valganciclovir—Vomiting—Pravastatin—coronary artery disease	5.4e-05	0.000224	CcSEcCtD
Valganciclovir—Hyperhidrosis—Lisinopril—coronary artery disease	5.39e-05	0.000224	CcSEcCtD
Valganciclovir—Diarrhoea—Captopril—coronary artery disease	5.39e-05	0.000224	CcSEcCtD
Valganciclovir—Dyspnoea—Timolol—coronary artery disease	5.36e-05	0.000223	CcSEcCtD
Valganciclovir—Dizziness—Telmisartan—coronary artery disease	5.35e-05	0.000222	CcSEcCtD
Valganciclovir—Dermatitis—Pravastatin—coronary artery disease	5.35e-05	0.000222	CcSEcCtD
Valganciclovir—Decreased appetite—Ramipril—coronary artery disease	5.34e-05	0.000222	CcSEcCtD
Valganciclovir—Somnolence—Timolol—coronary artery disease	5.34e-05	0.000222	CcSEcCtD
Valganciclovir—Asthenia—Furosemide—coronary artery disease	5.33e-05	0.000221	CcSEcCtD
Valganciclovir—Headache—Pravastatin—coronary artery disease	5.32e-05	0.000221	CcSEcCtD
Valganciclovir—Anorexia—Lisinopril—coronary artery disease	5.31e-05	0.000221	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Ramipril—coronary artery disease	5.31e-05	0.00022	CcSEcCtD
Valganciclovir—Fatigue—Ramipril—coronary artery disease	5.3e-05	0.00022	CcSEcCtD
Valganciclovir—Dyspepsia—Timolol—coronary artery disease	5.29e-05	0.00022	CcSEcCtD
Valganciclovir—Hypersensitivity—Losartan—coronary artery disease	5.28e-05	0.000219	CcSEcCtD
Valganciclovir—Nausea—Valsartan—coronary artery disease	5.27e-05	0.000219	CcSEcCtD
Valganciclovir—Pruritus—Furosemide—coronary artery disease	5.26e-05	0.000218	CcSEcCtD
Valganciclovir—Constipation—Ramipril—coronary artery disease	5.26e-05	0.000218	CcSEcCtD
Valganciclovir—Nausea—Olmesartan—coronary artery disease	5.24e-05	0.000218	CcSEcCtD
Valganciclovir—Vomiting—Trandolapril—coronary artery disease	5.24e-05	0.000218	CcSEcCtD
Valganciclovir—Diarrhoea—Perindopril—coronary artery disease	5.23e-05	0.000217	CcSEcCtD
Valganciclovir—Decreased appetite—Timolol—coronary artery disease	5.22e-05	0.000217	CcSEcCtD
Valganciclovir—Vomiting—Enalapril—coronary artery disease	5.22e-05	0.000217	CcSEcCtD
Valganciclovir—Hypotension—Lisinopril—coronary artery disease	5.21e-05	0.000216	CcSEcCtD
Valganciclovir—Dizziness—Captopril—coronary artery disease	5.21e-05	0.000216	CcSEcCtD
Valganciclovir—Dermatitis—Trandolapril—coronary artery disease	5.19e-05	0.000216	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Timolol—coronary artery disease	5.19e-05	0.000216	CcSEcCtD
Valganciclovir—Fatigue—Timolol—coronary artery disease	5.18e-05	0.000215	CcSEcCtD
Valganciclovir—Dermatitis—Enalapril—coronary artery disease	5.17e-05	0.000215	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—PLAT—coronary artery disease	5.17e-05	0.00102	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—coronary artery disease	5.16e-05	0.00102	CbGpPWpGaD
Valganciclovir—Headache—Trandolapril—coronary artery disease	5.16e-05	0.000214	CcSEcCtD
Valganciclovir—Vomiting—Telmisartan—coronary artery disease	5.15e-05	0.000214	CcSEcCtD
Valganciclovir—Asthenia—Losartan—coronary artery disease	5.14e-05	0.000214	CcSEcCtD
Valganciclovir—Headache—Enalapril—coronary artery disease	5.14e-05	0.000214	CcSEcCtD
Valganciclovir—Pain—Timolol—coronary artery disease	5.14e-05	0.000213	CcSEcCtD
Valganciclovir—Nausea—Niacin—coronary artery disease	5.12e-05	0.000213	CcSEcCtD
Valganciclovir—Dermatitis—Telmisartan—coronary artery disease	5.1e-05	0.000212	CcSEcCtD
Valganciclovir—Diarrhoea—Furosemide—coronary artery disease	5.08e-05	0.000211	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Lisinopril—coronary artery disease	5.08e-05	0.000211	CcSEcCtD
Valganciclovir—Pruritus—Losartan—coronary artery disease	5.07e-05	0.000211	CcSEcCtD
Valganciclovir—Headache—Telmisartan—coronary artery disease	5.07e-05	0.000211	CcSEcCtD
Valganciclovir—Feeling abnormal—Ramipril—coronary artery disease	5.07e-05	0.00021	CcSEcCtD
Valganciclovir—Dizziness—Perindopril—coronary artery disease	5.05e-05	0.00021	CcSEcCtD
Valganciclovir—Insomnia—Lisinopril—coronary artery disease	5.04e-05	0.000209	CcSEcCtD
Valganciclovir—Nausea—Pravastatin—coronary artery disease	5.04e-05	0.000209	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Ramipril—coronary artery disease	5.03e-05	0.000209	CcSEcCtD
Valganciclovir—Paraesthesia—Lisinopril—coronary artery disease	5.01e-05	0.000208	CcSEcCtD
Valganciclovir—Vomiting—Captopril—coronary artery disease	5.01e-05	0.000208	CcSEcCtD
Valganciclovir—Dyspnoea—Lisinopril—coronary artery disease	4.97e-05	0.000206	CcSEcCtD
Valganciclovir—Dermatitis—Captopril—coronary artery disease	4.96e-05	0.000206	CcSEcCtD
Valganciclovir—Somnolence—Lisinopril—coronary artery disease	4.96e-05	0.000206	CcSEcCtD
Valganciclovir—Feeling abnormal—Timolol—coronary artery disease	4.95e-05	0.000206	CcSEcCtD
Valganciclovir—Headache—Captopril—coronary artery disease	4.93e-05	0.000205	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Timolol—coronary artery disease	4.91e-05	0.000204	CcSEcCtD
Valganciclovir—Dizziness—Furosemide—coronary artery disease	4.91e-05	0.000204	CcSEcCtD
Valganciclovir—Dyspepsia—Lisinopril—coronary artery disease	4.91e-05	0.000204	CcSEcCtD
Valganciclovir—Diarrhoea—Losartan—coronary artery disease	4.91e-05	0.000204	CcSEcCtD
Valganciclovir—Nausea—Trandolapril—coronary artery disease	4.89e-05	0.000203	CcSEcCtD
Valganciclovir—Urticaria—Ramipril—coronary artery disease	4.88e-05	0.000203	CcSEcCtD
Valganciclovir—Nausea—Enalapril—coronary artery disease	4.88e-05	0.000203	CcSEcCtD
Valganciclovir—Vomiting—Perindopril—coronary artery disease	4.86e-05	0.000202	CcSEcCtD
Valganciclovir—Abdominal pain—Ramipril—coronary artery disease	4.86e-05	0.000202	CcSEcCtD
Valganciclovir—Body temperature increased—Ramipril—coronary artery disease	4.86e-05	0.000202	CcSEcCtD
Valganciclovir—Decreased appetite—Lisinopril—coronary artery disease	4.85e-05	0.000201	CcSEcCtD
Valganciclovir—Dermatitis—Perindopril—coronary artery disease	4.81e-05	0.0002	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.81e-05	0.0002	CcSEcCtD
Valganciclovir—Nausea—Telmisartan—coronary artery disease	4.81e-05	0.0002	CcSEcCtD
Valganciclovir—Fatigue—Lisinopril—coronary artery disease	4.81e-05	0.0002	CcSEcCtD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—coronary artery disease	4.79e-05	0.000946	CbGpPWpGaD
Valganciclovir—Headache—Perindopril—coronary artery disease	4.79e-05	0.000199	CcSEcCtD
Valganciclovir—Urticaria—Timolol—coronary artery disease	4.77e-05	0.000198	CcSEcCtD
Valganciclovir—Pain—Lisinopril—coronary artery disease	4.77e-05	0.000198	CcSEcCtD
Valganciclovir—Constipation—Lisinopril—coronary artery disease	4.77e-05	0.000198	CcSEcCtD
Valganciclovir—Abdominal pain—Timolol—coronary artery disease	4.75e-05	0.000197	CcSEcCtD
Valganciclovir—Body temperature increased—Timolol—coronary artery disease	4.75e-05	0.000197	CcSEcCtD
Valganciclovir—Dizziness—Losartan—coronary artery disease	4.74e-05	0.000197	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—PLG—coronary artery disease	4.73e-05	0.000934	CbGpPWpGaD
Valganciclovir—Vomiting—Furosemide—coronary artery disease	4.72e-05	0.000196	CcSEcCtD
Valganciclovir—Dermatitis—Furosemide—coronary artery disease	4.68e-05	0.000194	CcSEcCtD
Valganciclovir—Nausea—Captopril—coronary artery disease	4.68e-05	0.000194	CcSEcCtD
Valganciclovir—Headache—Furosemide—coronary artery disease	4.65e-05	0.000193	CcSEcCtD
Valganciclovir—Feeling abnormal—Lisinopril—coronary artery disease	4.59e-05	0.000191	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Lisinopril—coronary artery disease	4.56e-05	0.000189	CcSEcCtD
Valganciclovir—Vomiting—Losartan—coronary artery disease	4.56e-05	0.000189	CcSEcCtD
Valganciclovir—Nausea—Perindopril—coronary artery disease	4.54e-05	0.000189	CcSEcCtD
Valganciclovir—Hypersensitivity—Ramipril—coronary artery disease	4.53e-05	0.000188	CcSEcCtD
Valganciclovir—Dermatitis—Losartan—coronary artery disease	4.52e-05	0.000188	CcSEcCtD
Valganciclovir—Headache—Losartan—coronary artery disease	4.49e-05	0.000187	CcSEcCtD
Valganciclovir—Urticaria—Lisinopril—coronary artery disease	4.43e-05	0.000184	CcSEcCtD
Valganciclovir—Hypersensitivity—Timolol—coronary artery disease	4.43e-05	0.000184	CcSEcCtD
Valganciclovir—Nausea—Furosemide—coronary artery disease	4.41e-05	0.000183	CcSEcCtD
Valganciclovir—Asthenia—Ramipril—coronary artery disease	4.41e-05	0.000183	CcSEcCtD
Valganciclovir—Body temperature increased—Lisinopril—coronary artery disease	4.41e-05	0.000183	CcSEcCtD
Valganciclovir—Abdominal pain—Lisinopril—coronary artery disease	4.41e-05	0.000183	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—PLG—coronary artery disease	4.39e-05	0.000867	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	4.37e-05	0.000862	CbGpPWpGaD
Valganciclovir—Pruritus—Ramipril—coronary artery disease	4.35e-05	0.000181	CcSEcCtD
Valganciclovir—Asthenia—Timolol—coronary artery disease	4.31e-05	0.000179	CcSEcCtD
Valganciclovir—Nausea—Losartan—coronary artery disease	4.26e-05	0.000177	CcSEcCtD
Valganciclovir—Pruritus—Timolol—coronary artery disease	4.25e-05	0.000177	CcSEcCtD
Valganciclovir—Diarrhoea—Ramipril—coronary artery disease	4.21e-05	0.000175	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—APOB—coronary artery disease	4.19e-05	0.000826	CbGpPWpGaD
Valganciclovir—Diarrhoea—Timolol—coronary artery disease	4.11e-05	0.000171	CcSEcCtD
Valganciclovir—Hypersensitivity—Lisinopril—coronary artery disease	4.11e-05	0.000171	CcSEcCtD
Valganciclovir—Dizziness—Ramipril—coronary artery disease	4.06e-05	0.000169	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	4.06e-05	0.0008	CbGpPWpGaD
Valganciclovir—Asthenia—Lisinopril—coronary artery disease	4e-05	0.000166	CcSEcCtD
Valganciclovir—Dizziness—Timolol—coronary artery disease	3.97e-05	0.000165	CcSEcCtD
Valganciclovir—Pruritus—Lisinopril—coronary artery disease	3.94e-05	0.000164	CcSEcCtD
Valganciclovir—Vomiting—Ramipril—coronary artery disease	3.91e-05	0.000162	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—APOB—coronary artery disease	3.88e-05	0.000767	CbGpPWpGaD
Valganciclovir—Dermatitis—Ramipril—coronary artery disease	3.87e-05	0.000161	CcSEcCtD
Valganciclovir—Headache—Ramipril—coronary artery disease	3.85e-05	0.00016	CcSEcCtD
Valganciclovir—Vomiting—Timolol—coronary artery disease	3.82e-05	0.000159	CcSEcCtD
Valganciclovir—Diarrhoea—Lisinopril—coronary artery disease	3.81e-05	0.000158	CcSEcCtD
Valganciclovir—Dermatitis—Timolol—coronary artery disease	3.79e-05	0.000157	CcSEcCtD
Valganciclovir—Headache—Timolol—coronary artery disease	3.76e-05	0.000156	CcSEcCtD
Valganciclovir—Dizziness—Lisinopril—coronary artery disease	3.69e-05	0.000153	CcSEcCtD
Valganciclovir—Nausea—Ramipril—coronary artery disease	3.65e-05	0.000152	CcSEcCtD
Valganciclovir—Nausea—Timolol—coronary artery disease	3.57e-05	0.000148	CcSEcCtD
Valganciclovir—Vomiting—Lisinopril—coronary artery disease	3.54e-05	0.000147	CcSEcCtD
Valganciclovir—Dermatitis—Lisinopril—coronary artery disease	3.51e-05	0.000146	CcSEcCtD
Valganciclovir—Headache—Lisinopril—coronary artery disease	3.49e-05	0.000145	CcSEcCtD
Valganciclovir—Nausea—Lisinopril—coronary artery disease	3.31e-05	0.000138	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.31e-05	0.000654	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.07e-05	0.000607	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—coronary artery disease	2.62e-05	0.000518	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—coronary artery disease	2.43e-05	0.000481	CbGpPWpGaD
